Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.
about
Oxidative Stress Signaling in Alzheimers DiseaseOxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventionsMitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic interventionTriad of Risk for Late Onset Alzheimer's: Mitochondrial Haplotype, APOE Genotype and Chromosomal SexMitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survivalAmyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive declineAlzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons.MtSNPscore: a combined evidence approach for assessing cumulative impact of mitochondrial variations in disease.Oxidative stress and mitochondrial dysfunction in Alzheimer's disease.Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscleSynergy between chronic corticosterone and sodium azide treatments in producing a spatial learning deficit and inhibiting cytochrome oxidase activity.Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.Functional brain imaging in the resting state and during activation in Alzheimer's disease. Implications for disease mechanisms involving oxidative phosphorylation.The neurodegenerative mitochondriopathies.Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons.Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies.Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change?Perturbed glucose metabolism: insights into multiple sclerosis pathogenesisRole of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's diseaseMitoLSDB: a comprehensive resource to study genotype to phenotype correlations in human mitochondrial DNA variations.Mitochondrial oxygen consumption deficits in skeletal muscle isolated from an Alzheimer's disease-relevant murine modelAbnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeuticsMitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.Mitochondrial failures in Alzheimer's disease.Tracing the neuroanatomical profiles of reward pathways with markers of neuronal activation.Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?Mitoenergetic failure in Alzheimer disease.Oxidative stress and transcriptional regulation in Alzheimer diseaseThe Alzheimer's disease mitochondrial cascade hypothesis: an updateAmyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid.Abnormal mitochondrial dynamics and neurodegenerative diseases.Aerobic glycolysis in the primate brain: reconsidering the implications for growth and maintenance.Signaling pathway cross talk in Alzheimer's diseaseThe role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases.Mitochondrial Dysfunction in Autism Spectrum Disorders.Nuclear but not mitochondrial-encoded oxidative phosphorylation genes are altered in aging, mild cognitive impairment, and Alzheimer's disease.Amyloid is essential but insufficient for Alzheimer causation: addition of subcellular cofactors is required for dementia.Brain energy metabolizing enzymes in Alzheimer's disease: alpha-ketoglutarate dehydrogenase complex and cytochrome oxidase.Inherent abnormalities in oxidative metabolism in Alzheimer's disease: interaction with vascular abnormalities.
P2860
Q22241327-4F3F1146-05EA-4F6F-B864-C2DA41925816Q26851676-F625C531-776E-4B39-A532-46CF44FE3937Q26865358-50BDAE71-BC07-47DD-965B-06188383DA96Q28077056-E79D1F1B-D846-4699-96BB-37323B7C95C0Q28580488-1F4CFF5C-6741-4DAC-B5E6-81AE66949CE4Q30476347-B9A1747F-1BEE-41D3-B3A9-A956C4EB74D1Q33323272-98F113F6-94EA-49F5-95ED-DA8A62EACDD3Q33503932-739291C7-5F4C-467D-A47D-F35C572F41D2Q33555956-DA9FA103-008D-41E3-9EB0-11159F9F9F80Q33557364-D7717345-4257-41FD-9CF8-DFB3041ACB45Q33558336-EAEA23E4-ED85-4284-881F-D1D53944C74CQ33585950-C2E30DA7-D282-4FD7-9543-F3D403E7865BQ33836224-DB05FB75-EDD3-43A2-A3F9-5EBC8B8B1198Q33957065-900EDC0E-EEBB-49ED-9DCC-04096412D0FFQ34047984-EC914A42-218E-4DB2-924A-0FA4875683CCQ34073939-EB5FC1F9-1D03-4CA2-8D0F-2F0DAE6B52D4Q34490690-50BCA548-AE1B-403F-9B9D-AAF28CC59A1BQ34595607-2BF916DE-A388-4767-A2DA-F378F44132E4Q34667337-31C66D92-E756-44FC-AAA4-06DF28D6F281Q34667750-A1828578-FC8E-4E90-9F6E-A4324E6137AAQ35093852-BB675F98-49C5-4626-91C9-AB1D25658DF6Q35737647-8851153D-32EF-45A6-A65F-53970B3193D5Q35898628-96A02DEF-DF3C-49D6-8230-D6BA334886B8Q36000745-40D60C80-8D57-427C-9675-BB1724FD571BQ36012736-9591197D-9305-4B5B-B29F-AA9BF06CF984Q36456888-336F327B-E30B-407B-86DC-52215A92DCDFQ36522646-BCC4F4A7-369E-4EEF-B0C1-EE61AE9BA75BQ37036247-8485DE78-584A-4A73-A606-CF454D866779Q37261159-F6863350-7AAE-442A-A3B0-0749A55FBE4EQ37261203-435BC8BE-155E-4D1F-8C4C-A527807B9F37Q37376501-F02A2A07-1DCF-4BF1-8F25-DD1912BA137BQ37607449-20BFCB36-1330-44D6-8D6E-FCA2EFE5BBDFQ38159417-EEC003D4-A4D0-45C2-A183-AB93C039A0F1Q38200151-535E7525-4FF2-498E-B9BC-D9529E003814Q38532744-E13BF73D-16D0-4D5E-AB5A-C578928A270FQ39032450-D55E0902-5ACD-47C7-BD6D-A377A0DCA636Q39236946-F9598B05-8C46-457A-8729-B8F966C099D3Q39309631-F13CC1D5-F5EC-4BBD-B1DD-737EBAD776D3Q41611084-8E96AEED-B1DC-4D95-9BB6-C049C0E83C85Q41611149-F5C98970-66F8-4D2F-BDC6-8F19A7E7F639
P2860
Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.
@en
Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.
@nl
type
label
Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.
@en
Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.
@nl
prefLabel
Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.
@en
Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.
@nl
P2093
P1476
Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.
@en
P2093
P304
P356
10.1016/0169-328X(94)90147-3
P577
1994-07-01T00:00:00Z